These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

116 related items for PubMed ID: 525067

  • 21. [The uric acid-lowering action of benzbromarone effervescent granules and allopurinol. Comparative studies (author's transl)].
    Mertz DP.
    MMW Munch Med Wochenschr; 1978 Oct 20; 120(42):1387-90. PubMed ID: 101792
    [Abstract] [Full Text] [Related]

  • 22. [A new drug therapy for gout and hyperuricemia. Long term results].
    Masbernard A, Giudicelli CP.
    Sem Hop Ther; 1976 Oct 20; 52(7-8):369-74. PubMed ID: 996556
    [No Abstract] [Full Text] [Related]

  • 23. [Benzbromarone in the treatment of gout].
    Kawenoki-Minc E, Brzozowska-Jurkowska AM.
    Reumatologia; 1980 Oct 20; 18(1):61-7. PubMed ID: 6994191
    [No Abstract] [Full Text] [Related]

  • 24. [The effect of benzbromarone on hyperlipidemia in gout].
    Marinchev L, Kŭnev K.
    Vutr Boles; 1990 Oct 20; 29(5):99-102. PubMed ID: 2080622
    [Abstract] [Full Text] [Related]

  • 25. [Clinical studies on hyperuricemia and gout after transplantation].
    Imanishi M, Ikegami M, Ishii T, Nishioka T, Uemura T, Kunikata S, Kanda H, Matsuura T, Akiyama T, Kurita T.
    Hinyokika Kiyo; 1990 Aug 20; 36(8):893-6. PubMed ID: 2239590
    [Abstract] [Full Text] [Related]

  • 26. [Efficacy and tolerance of a new benzbromarone preparation].
    Jelke K, Neubauer M, Krause G, Jüttner A, Angar T, Grosse-Kielisch C, Bach GL.
    Med Welt; 1980 May 23; 31(21):821-2. PubMed ID: 7392938
    [No Abstract] [Full Text] [Related]

  • 27. [Pathogenesis and treatment of fast-induced hyperuricemia using benzbromarone].
    Schräpler P, Schulz E.
    Med Welt; 1976 Mar 19; 27(12):575-81. PubMed ID: 1263801
    [No Abstract] [Full Text] [Related]

  • 28. [On clinical experiences with 2-ethyl-3(4-hydroxy-3,5-dibrombenzoyl)-benzofuran ("Benzbromaron") in the therapy of gout and hyperuricemia].
    Kotzaurek R, Hueber EF.
    Wien Med Wochenschr; 1968 Nov 23; 118(47):1014-8. PubMed ID: 5704263
    [No Abstract] [Full Text] [Related]

  • 29. [The effect of benzbromarone on fasting-hyperuricemia as a model (author's transl)].
    Schräpler P, Kleinschmidt A, Haese E.
    Med Klin; 1978 Jun 09; 73(23):861-6. PubMed ID: 661730
    [Abstract] [Full Text] [Related]

  • 30. [Current therapy: combined drug therapy of hyperuricemia, gout and alcohol induced fatty liver].
    Mertz DP.
    Fortschr Med; 1983 May 12; 101(18):851-3. PubMed ID: 6862346
    [No Abstract] [Full Text] [Related]

  • 31. [The effect on uric acid and other laboratory parameters. A long-term study].
    Dorn M.
    ZFA (Stuttgart); 1982 Feb 20; 58(5):296-300. PubMed ID: 7043937
    [No Abstract] [Full Text] [Related]

  • 32. [Comparative study of uric acid concentration in serum and saliva of healthy or hyperuricemic subjects].
    Schermann JM, Meunier J, Ricordel I, Masbernard A, Giudicelli C.
    Ann Biol Clin (Paris); 1977 Feb 20; 35(6):467-72. PubMed ID: 615505
    [Abstract] [Full Text] [Related]

  • 33. [Therapy with alllopurinol and benzbromarone, single and combined. Renal elimination of lithogenous and colloid protective substances (author's transl)].
    Mertz DP.
    Med Klin; 1977 Apr 15; 72(15):664-8. PubMed ID: 857138
    [Abstract] [Full Text] [Related]

  • 34. [Effect of uric acid lowering drugs in low dosage in patients with hyperuricemia and hypertriglyceridemia in a randomized group study].
    Arntz HR, Dreykluft HR, Leonhardt H.
    Fortschr Med; 1979 Jul 19; 97(27):1212-4. PubMed ID: 457017
    [Abstract] [Full Text] [Related]

  • 35. [Prevention of urinary calculi by means of a benzbromarone-citrate combination].
    Bach D, Hesse A, Strenge A, Vahlensieck W.
    Fortschr Med; 1980 Nov 27; 98(44):1752-5. PubMed ID: 7461567
    [Abstract] [Full Text] [Related]

  • 36. [Uric acid lowering effects of benzbromarone (Harolan) by increasing uric acid excretion].
    Fortschr Med; 1979 May 03; 97(17):835-6. PubMed ID: 437646
    [No Abstract] [Full Text] [Related]

  • 37. Pharmacokinetic and clinical studies of a new uricosuric agent - benzbromarone.
    Yu TF.
    J Rheumatol; 1976 Sep 03; 3(3):305-12. PubMed ID: 978666
    [Abstract] [Full Text] [Related]

  • 38. [Treating gout with benzbromarone (author's transl)].
    Bosmanský K, Trnavský K.
    Cas Lek Cesk; 1979 Feb 02; 118(5):153-6. PubMed ID: 436143
    [No Abstract] [Full Text] [Related]

  • 39. [Excretion and serum concentrations of allopurinol, oxipurinol and oxipurines in combined treatment with allopurinol and benzbromarone in increasing doses].
    Mertz DP, Borner K.
    Med Welt; 1983 Sep 09; 34(36):974-9. PubMed ID: 6633222
    [No Abstract] [Full Text] [Related]

  • 40. [The importance of benziodarone in the treatment of gout and hyperuricemic syndrome].
    Lindusková M, Vykydal M.
    Cas Lek Cesk; 1990 Nov 30; 129(48):1524-5. PubMed ID: 2257602
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.